Abstract
Overexpression of the de-ubiquitinating enzyme UCH-L1 leads to inclusion formation in response to proteasome impairment. These inclusions contain components of the ubiquitin-proteasome system and α-synuclein confirming that the ubiquitin-proteasome system plays an important role in protein aggregation. The processes involved are very complex and so we have chosen to take a systems biology approach to examine the system whereby we combine mathematical modelling with experiments in an iterative process. The experiments show that cells are very heterogeneous with respect to inclusion formation and so we use stochastic simulation. The model shows that the variability is partly due to stochastic effects but also depends on protein expression levels of UCH-L1 within cells. The model also indicates that the aggregation process can start even before any proteasome inhibition is present, but that proteasome inhibition greatly accelerates aggregation progression. This leads to less efficient protein degradation and hence more aggregation suggesting that there is a vicious cycle. However, proteasome inhibition may not necessarily be the initiating event. Our combined modelling and experimental approach show that stochastic effects play an important role in the aggregation process and could explain the variability in the age of disease onset. Furthermore, our model provides a valuable tool, as it can be easily modified and extended to incorporate new experimental data, test hypotheses and make testable predictions.
Highlights
UCH-L1 (P09936) is a de-ubiquitinating enzyme (DUB) which binds to small polyubiquitinated proteins and cleaves ubiquitin molecules (P62988)
The model predicts that no damage occurs to UCH-L1 or a-synuclein and so no inhibition of chaperone mediated autophagy (CMA) takes place
We initially modelled UCH-L1 overexpression by increasing the initial amount of UCHL1 and the synthesis rate by a factor of 2 and used an Systems Biology Markup Language (SBML) event structure to decrease the rate of proteasome degradation by 70% after 20 hours
Summary
UCH-L1 (P09936) is a de-ubiquitinating enzyme (DUB) which binds to small polyubiquitinated proteins and cleaves ubiquitin molecules (P62988). UCH-L1 is normally abundant in brain tissue where it is localised to neurons (1-2% of soluble neuronal cell protein) [3]. It is highly expressed in testes but UCH-L1 levels are low in all other tissues due to silencing by methylation [4]. UCH-L1 is found in Lewy bodies of Parkinson’s disease (PD) patients and tangles in Alzheimer’s disease (AD) patients [7] It is oxidatively damaged in these diseases and loses about 40–80% of its activity [8]. The level of soluble UCH-L1 protein is inversely proportional to the number of tangles in AD brains [9]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.